Hims & Hers Health Inc. completed an upsized private offering of $350 million in convertible senior notes.
The notes carry a 0.00% interest rate and mature in 2032.
The transaction settled on May 21, 2026.
Hims & Hers will use the proceeds to fund international expansion, including the proposed acquisition of Eucalyptus.
The capital will also support investments in technology infrastructure and AI capabilities.
The company's stock price declined earlier in the week following the initial announcement.
This decline occurred as investors weighed the potential for future share dilution.
While the raise increases the company's debt load, it provides financial flexibility for overseas and technological growth.